Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical Trial.
Moore CM, Robertson NL, Jichi F, Damola A, Ambler G, Giganti F, Ridout AJ, Bott SR, Winkler M, Ahmed HU, Arya M, Mitra AV, McCartan N, Freeman A, Jameson C, Castro R, Gambarota G, Whitcher BJ, Allen C, Kirkham A, Emberton M. Moore CM, et al. Among authors: robertson nl. J Urol. 2017 Apr;197(4):1006-1013. doi: 10.1016/j.juro.2016.11.090. Epub 2016 Nov 19. J Urol. 2017. PMID: 27871928 Free article. Clinical Trial.
MAPPED study design: a 6 month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging.
Robertson NL, Moore CM, Ambler G, Bott SR, Freeman A, Gambarota G, Jameson C, Mitra AV, Whitcher B, Winkler M, Kirkham A, Allen C, Emberton M. Robertson NL, et al. Contemp Clin Trials. 2013 Jan;34(1):80-9. doi: 10.1016/j.cct.2012.10.003. Epub 2012 Oct 17. Contemp Clin Trials. 2013. PMID: 23085153 Clinical Trial.
Re: Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging: P. A. Pinto, P. H. Chung, A. R. Rastinehad, A. A. Baccala, Jr., J. Kruecker, C. J. Benjamin, S. Xu, P. Yan, S. Kadoury, C. Chua, J. K. Locklin, B. Turkbey, J. H. Shih, S. P. Gates, C. Buckner, G. Bratslavsky, W. M. Linehan, N. D. Glossop, P. L. Choyke and B. J. Wood J Urol 2011; 186: 1281-1285.
Robertson NL, Moore CM, Emberton M. Robertson NL, et al. J Urol. 2012 Apr;187(4):1511-2. doi: 10.1016/j.juro.2011.12.007. Epub 2012 Feb 17. J Urol. 2012. PMID: 22341821 No abstract available.
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial.
Giganti F, Moore CM, Robertson NL, McCartan N, Jameson C, Bott SRJ, Winkler M, Gambarota G, Whitcher B, Castro R, Emberton M, Allen C, Kirkham A. Giganti F, et al. Among authors: robertson nl. Eur Radiol. 2017 Nov;27(11):4767-4774. doi: 10.1007/s00330-017-4858-0. Epub 2017 May 18. Eur Radiol. 2017. PMID: 28523355 Free PMC article. Clinical Trial.
Prostate cancer detection using quantitative T2 and T2 -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance.
Giganti F, Gambarota G, Moore CM, Robertson NL, McCartan N, Jameson C, Bott SRJ, Winkler M, Whitcher B, Castro-Santamaria R, Emberton M, Allen C, Kirkham A. Giganti F, et al. Among authors: robertson nl. J Magn Reson Imaging. 2018 Jun;47(6):1646-1653. doi: 10.1002/jmri.25891. Epub 2017 Nov 14. J Magn Reson Imaging. 2018. PMID: 29135073 Free article. Clinical Trial.
Extensive disease among potential candidates for hemi-ablative focal therapy for prostate cancer.
Takeda T, Tin AL, Corradi RB, Alvim R, Hashimoto T, Ito Y, Nguyen DP, Mamoor M, Robertson NL, Vargas HA, Benfante NE, Sjoberg DD, Eastham JA, Scardino PT, Fine SW, Oya M, Touijer KA. Takeda T, et al. Among authors: robertson nl. Int J Urol. 2020 Feb;27(2):179-185. doi: 10.1111/iju.14161. Epub 2019 Dec 13. Int J Urol. 2020. PMID: 31833113 Free PMC article.
37 results